Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/44732
Title: Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain
Author: Almenar, Luis
Díaz, Beatriz
Quesada, Aurelio
Crespo, Carlos
Martí, Belén
Mealing, Stuart
Linde, Cecilia
Daubert, Claude
Keywords: Economia de la salut
Malalties del cor
Espanya
Medical economics
Heart diseases
Spain
Issue Date: Apr-2013
Publisher: Cambridge University Press
Abstract: Objectives: The aim of the study was to combine clinical results from the European Cohort of the REVERSE study and costs associated with the addition of cardiac resynchronization therapy (CRT) to optimal medical therapy (OMT) in patients with mild symptomatic (NYHA I-II) or asymptomatic left ventricular dysfunction and markers of cardiac dyssynchrony in Spain. Methods: A Markov model was developed with CRT + OMT (CRT-ON) versus OMT only (CRT-OFF) based on a retrospective cost-effectiveness analysis. Raw data was derived from literature and expert opinion, reflecting clinical and economic consequences of patient"s management in Spain. Time horizon was 10 years. Both costs (euro 2010) and effects were discounted at 3 percent per annum. Results: CRT-ON showed higher total costs than CRT-OFF; however, CRT reduced the length of hospitalization in ICU by 94 percent (0.006 versus 0.091 days) and general ward in by 34 percent (0.705 versus 1.076 days). Surviving CRT-ON patients (88.2 percent versus 77.5 percent) remained in better functional class longer, and they achieved an improvement of 0.9 life years (LYGs) and 0.77 years quality-adjusted life years (QALYs). CRT-ON proved to be cost-effective after 6 years, except for the 7th year due to battery depletion. At 10 years, the results were 18,431 per LYG and 21,500 per QALY gained. Probabilistic sensitivity analysis showed CRT-ON was cost-effective in 75.4 percent of the cases at 10 years. Conclusions: The use of CRT added to OMT represents an efficient use of resources in patients suffering from heart failure in NYHA functional classes I and II.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1017/S0266462313000123
It is part of: International Journal of Technology Assessment in Health Care, 2013, vol. 29, num. 2, p. 140-146
Related resource: http://dx.doi.org/10.1017/S0266462313000123
URI: http://hdl.handle.net/2445/44732
ISSN: 0266-4623
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
620491.pdf176.11 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.